Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
View ORCID ProfileGillian S. Dite, View ORCID ProfileNicholas M. Murphy, View ORCID ProfileRichard Allman
doi: https://doi.org/10.1101/2021.03.09.21253237
Gillian S. Dite
1Genetic Technologies Ltd., Fitzroy, Victoria, Australia
Nicholas M. Murphy
1Genetic Technologies Ltd., Fitzroy, Victoria, Australia
Richard Allman
1Genetic Technologies Ltd., Fitzroy, Victoria, Australia
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted March 28, 2021.
Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
Gillian S. Dite, Nicholas M. Murphy, Richard Allman
medRxiv 2021.03.09.21253237; doi: https://doi.org/10.1101/2021.03.09.21253237
Subject Area
Subject Areas
- Addiction Medicine (329)
- Allergy and Immunology (649)
- Anesthesia (174)
- Cardiovascular Medicine (2502)
- Dermatology (210)
- Emergency Medicine (385)
- Epidemiology (11977)
- Forensic Medicine (10)
- Gastroenterology (718)
- Genetic and Genomic Medicine (3900)
- Geriatric Medicine (362)
- Health Economics (653)
- Health Informatics (2515)
- Health Policy (973)
- Hematology (350)
- HIV/AIDS (813)
- Medical Education (386)
- Medical Ethics (106)
- Nephrology (416)
- Neurology (3656)
- Nursing (205)
- Nutrition (544)
- Oncology (1901)
- Ophthalmology (554)
- Orthopedics (230)
- Otolaryngology (299)
- Pain Medicine (243)
- Palliative Medicine (71)
- Pathology (461)
- Pediatrics (1071)
- Primary Care Research (434)
- Public and Global Health (6327)
- Radiology and Imaging (1340)
- Respiratory Medicine (845)
- Rheumatology (389)
- Sports Medicine (334)
- Surgery (426)
- Toxicology (51)
- Transplantation (179)
- Urology (155)